<DOC>
	<DOC>NCT01925625</DOC>
	<brief_summary>HYPOTHESIS In a high risk population the EarlyCDT-Lung test reduces the incidence of late stage tumours;3 / 4 / Unclassified (U) at diagnosis compared to normal clinical practice.</brief_summary>
	<brief_title>Early Cancer Detection Test - Lung Cancer Scotland</brief_title>
	<detailed_description>AIMS To assess the effectiveness of EarlyCDT-Lung test in increasing early stage lung cancer detection, thereby reducing the rate of late stage (3 / 4 / U) presentation, compared to normal clinical practice; to assess the cost-effectiveness of EarlyCDT-Lung test compared to normal clinical practice; to assess the effectiveness of EarlyCDT-Lung test in reducing adverse outcomes including potential psychological and behavioural consequences.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1. Participant is willing and able to give informed consent for participation in the study 2. Male or female aged 50 years to 75 years 3. Current or Exsmoker with at least 20 year pack history 4. or Less than 20 year pack history but with family history of lung cancer in a 1st degree relative (mother, father, sister, brother, child) 5. ECOG Status: 0, 1 and 2 (Eastern Cooperative Oncology Group) Grade ECOG 0 Fully active, able to carry on all predisease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours 6. Geographical postal sectors of: NHS Geographical Area Eligible Postcodes Tayside DD1 DD11, PH1PH3 , PH6PH8, PH10, PH11, PH13, PH15 &amp; PH16 Greater Glasgow &amp; Clyde G1G5, G11 G15, G20G22, G3134, G40 G46, G51 G53, G60G62 &amp;G64, G66 &amp; G69, G72 &amp; G73, G76G78, G81G83 PA1PA8 (except PA6), PA11PA16 &amp; PA19 1. History of any cancer other than nonmelanomatous skin cancer, cervical cancer in situ. 2. Symptoms suggestive of lung cancer within past 6 months (haemoptysis, unintentional weight loss (at least 5% in preceding 6 months). 3. Patients for whom the GP considers invitation to the study would cause undue distress. 4. Patients with other terminal disease. 5. Patients on prolonged / continuous use (&gt; 3months) of cytotoxic/ immunosuppressant drugs eg: Cyclophosphamide. Monotherapy using glucocorticoids/ steroids eg prednisolone is NOT an exclusion criteria.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>